Cited by 60Prion Diseases and Protein MisfoldingAlzheimer's disease research and treatmentsAmyloidosis: Diagnosis, Treatment, Outcomes

Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses

Gajdusek, D. Carleton·1994·Molecular Neurobiology

Abstract

The unconventional viruses of the transmissible subacute spongiform encephalopathies (kuru-CJD-GSS-FFI-scrapie-BSE) are nucleants spontaneously generated from host precursor proteins altered to beta-pleated sheet configuration that polymerize into insoluble infectious amyloid fibrils. The de novo conversion to infectious amyloids is facilitated or accelerated by many different point mutations causing amino acid changes, a stop codon, or octapeptide inserts that increase the likelihood of spontaneous conversion to infectious configuration by many orders of magnitude. Similar nucleating induction of configurational change to amyloid probably occurs in other amyloidoses of brain and in systemic amyloidoses. Thus, all amyloids, particularly so-called fibrillar amyloid enhancing factors, may be considered to be infectious scrapie-like agents. These events probably occur extracellularly, thus we are attempting to reproduce them in vitro, even from synthetic polypeptides.

Integrity signals

Registry

Crossref · 10.1007/bf02778003

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pathologic similarities with prion disease suggest that the formation and spread of proteinaceous lesions might involve a common molecular mechanism, corruptive protein templating.

    “Pathologic similarities with prion disease suggest that the formation and spread of these proteinaceous lesions might involve a common molecular mechanism – corruptive protein templating.”

The citation lists haven’t been fetched yet

References 62 · Cited by 60

Authors
Gajdusek, D. C.
Affiliations
National Institutes of Health (US)
Corresponding author
Gajdusek, D. Carleton
Venue
Molecular Neurobiology
Published
1994-02
Volume
8
Issue
1
Pages
1-13
ISSN
  • 0893-7648 (ISSN-L)
  • 1559-1182
OpenAlex
W2021561354
Cited by
60
References
62
Citations by year
2025: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2013: 3 · 2012: 3
FWCI
0.50
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Amyloidosis: Diagnosis, Treatment, Outcomes
Keywords
prion disease, prions, kuru, Creutzfeldt-Jakob disease, fatal familial insomnia, scrapie, bovine spongiform encephalopathy, point mutations, synthetic polypeptides
MeSH terms
Alzheimer Disease, Amyloid, Amyloidosis, DNA Mutational Analysis, Ethnicity, Genes, Humans, Polymers, Prealbumin, Protein Processing, Post-Translational, Global Health, Incidence, Amyloid beta-Protein Precursor, Prion Diseases, Point Mutation, Protein Structure, Secondary, Protein Folding, Amyloid Neuropathies, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review